Hematology TimesRadiation increases risk of death from CML, other leukemiasJuly 1, 2015Leukemia, Myelodysplasia, TransplantationALLCML
Hematology TimesInactivating an enzyme can eradicate T-ALLJune 25, 2015Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsEHA: Inotuzumab rallies against refractory/relapsed ALLJune 14, 2015ALLLymphoma & Plasma Cell Disorders
Hematology TimesStudy reveals potential target for T-ALLJune 9, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesCAR produces high CR rate in adults with rel/ref ALLJune 6, 2015Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesBreastfeeding may lower risk of ALLJune 2, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesHow a vaccine may reduce the risk of ALLMay 19, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesMRD doesn’t suggest need for more treatmentMay 18, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesInhibitor may benefit certain ALL patientsMay 9, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesReversing glucocorticoid resistance in ALLMay 6, 2015Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesCDK inhibitor proves active against AML, ALLApril 26, 2015Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology TimesDrug approved to treat CML, ALL in CanadaApril 7, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesEngineered protein overcomes radiation resistance in ALLMarch 31, 2015Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesIncreasing cell signaling to eradicate Ph+ ALLMarch 30, 2015Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesIsrael approves ponatinib for CML, Ph+ ALLMarch 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
